142 related articles for article (PubMed ID: 3416661)
1. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
[TBL] [Abstract][Full Text] [Related]
2. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.
Vistica DT
Biochim Biophys Acta; 1979 Jan; 550(2):309-17. PubMed ID: 569503
[TBL] [Abstract][Full Text] [Related]
4. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.
Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A
Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500
[TBL] [Abstract][Full Text] [Related]
5. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG
Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130
[TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
Yagi MJ; Bekesi JG
Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
[TBL] [Abstract][Full Text] [Related]
7. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent.
Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG
J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cells.
Vistica DT
Blood; 1980 Sep; 56(3):427-9. PubMed ID: 7407411
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of alpha-aminoisobutyric acid transport by lactating rat mammary gland.
Shennan DB; McNeillie SA
J Dairy Res; 1994 Feb; 61(1):9-19. PubMed ID: 8188948
[TBL] [Abstract][Full Text] [Related]
10. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells.
Dufour M; Panasci LC; St Germain J; Boulet L
Cancer Chemother Pharmacol; 1985; 15(2):125-31. PubMed ID: 4017161
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neutral and cationic amino acid transport in Xenopus oocytes.
Campa MJ; Kilberg MS
J Cell Physiol; 1989 Dec; 141(3):645-52. PubMed ID: 2592432
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
Yagi MJ; Bekesi JG
Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
[TBL] [Abstract][Full Text] [Related]
13. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
Yagi MJ; Zanjani M; Holland JF; Bekesi JG
Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428
[TBL] [Abstract][Full Text] [Related]
14. System ASC and sodium-independent neutral amino acid transport in muscle of uremic rats.
Maroni BJ; Karapanos G; Mitch WE
Am J Physiol; 1986 Jul; 251(1 Pt 2):F81-6. PubMed ID: 3524267
[TBL] [Abstract][Full Text] [Related]
15. Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).
Verlicchi F; Boschi S; Visani G; Guidi A; Tosi P; Cavo M; Tura S
Blut; 1990 Nov; 61(5):311-3. PubMed ID: 2271778
[TBL] [Abstract][Full Text] [Related]
16. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.
Langen KJ; Mühlensiepen H; Holschbach M; Hautzel H; Jansen P; Coenen HH
J Nucl Med; 2000 Jul; 41(7):1250-5. PubMed ID: 10914918
[TBL] [Abstract][Full Text] [Related]
17. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
Vistica DT; Toal JN; Rabinovitz M
Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
[TBL] [Abstract][Full Text] [Related]
19. Neutral amino acid transport in embryonal carcinoma cells.
Zuzack JS; Tasca RJ; DiZio SM
J Cell Physiol; 1985 Mar; 122(3):379-86. PubMed ID: 3968192
[TBL] [Abstract][Full Text] [Related]
20. A multicomponent analysis of amino acid transport systems in human lymphocytes. 1. Kinetic parameters of the A and L systems and pathways of uptake of naturally occurring amino acids in blood lymphocytes.
Segel GB; Simon W; Lichtman MA
J Cell Physiol; 1983 Sep; 116(3):372-8. PubMed ID: 6604062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
